Register entry
Dexcel Ltd.
- Registered sites
- 2
- Drug products
- 2
- Live patents
- 9
- Countries
- 1
- Base
- Israel
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingLabellingFinished drug manufacturePackaging
Sites
Facilities
2| Site | Location | Operations | FEI |
|---|---|---|---|
| Dexcel Ltd. | Or AkivaIsrael | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3002806801 |
| Dexcel Pharma Technologies - Yokneam Factory | Yokneam IllitIsrael | Labelling, Finished drug manufacture, Packaging | 3008404887 |
Exclusivity
Patents
9Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | Dec 2036 |
| HEMADY | DEXAMETHASONE | Dec 2037 |
| LANSOPRAZOLE | LANSOPRAZOLE | Apr 2036 |
| OMEPRAZOLE | OMEPRAZOLE | Jan 2030 |
| OMEPRAZOLE | OMEPRAZOLE | Dec 2036 |
Catalogue
Marketed products
2Showing 2 of 2.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Omeprazole | TABLET, DELAYED RELEASE | DRUG FOR FURTHER PROCESSING |
| - | Omeprazole | TABLET, DELAYED RELEASE | DRUG FOR FURTHER PROCESSING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.